Li Yuan, Lv Xuefei, Jiang Hao, Li Xiaoqiong, Deng Yulin
Beijing Key Laboratory for Separation and Analysis in Biomedicine and Pharmaceuticals, School of Medical Technology, Beijing Institute of Technology, Beijing, 100081, China.
Appl Biochem Biotechnol. 2024 Dec;196(12):8925-8939. doi: 10.1007/s12010-024-05022-1. Epub 2024 Jul 31.
Cascaded amplification showed promising potential for detection of trace target miRNAs in molecular diagnosis and prevention of many diseases. In this study, miRNA21 was chosen as the target, and rolling circle amplification (RCA)-based DNA nanoscaffold was integrated with target triggered RNA-cleaving DNAzyme for sensitive detection of miRNA21. That is, the H1 probe was bound with the long-chain product of RCA to self-assemble into DNA nanoscaffold. Target miRNA21 triggered the hybridization chain reaction (HCR) located on the nanoscaffold, and led to rapid proximity of DNAzyme fragments modified at both ends of the H2 probe, which realized the cyclic cleavage of self-quenching substrate probe efficiently, and the fluorescence signal was restored. The results demonstrated that the proposed assay was sensitive, 0.76 pM of miRNA21 can be detected. The proposed assay was specific; only one-base mismatched miRNA21 can be effectively recognized, other nucleic acid sequence and the serum matrix did not cause any interference. The proposed assay was accurate; recoveries from 82.1 to 115.0% can be obtained in the spiked fetal bovine serum (FBS). The flexible and programmable characteristics of DNA nanoscaffold and DNAzyme provide a confident and robust strategy for more sensitive nucleic acid detection, and can be developed to be a universal sensing platform for detecting other miRNAs just needing modification on the corresponding sequence of H1 probe in HCR.
级联放大在许多疾病的分子诊断和预防中对痕量目标微小RNA(miRNA)的检测显示出了广阔的应用前景。在本研究中,选择miRNA21作为目标,基于滚环扩增(RCA)的DNA纳米支架与目标触发的RNA切割脱氧核酶相结合,用于miRNA21的灵敏检测。即,H1探针与RCA的长链产物结合,自组装成DNA纳米支架。目标miRNA21触发位于纳米支架上的杂交链式反应(HCR),并导致H2探针两端修饰的脱氧核酶片段快速靠近,从而高效实现自猝灭底物探针的循环切割,荧光信号得以恢复。结果表明,所提出的检测方法具有灵敏性,能够检测到0.76 pM的miRNA21。该检测方法具有特异性,仅能有效识别单碱基错配的miRNA21,其他核酸序列和血清基质均不会产生任何干扰。该检测方法具有准确性,在加标的胎牛血清(FBS)中回收率可达82.1%至115.0%。DNA纳米支架和脱氧核酶的灵活可编程特性为更灵敏的核酸检测提供了可靠且稳健的策略,并且可以开发成为一个通用的传感平台,用于检测其他miRNA,只需对HCR中H1探针的相应序列进行修饰即可。